These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30371327)

  • 1. Selection of β-Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13-Year Nationwide Population-Based Study in Asia.
    Wu VC; Chen SW; Ting PC; Chang CH; Wu M; Lin MS; Hsieh MJ; Wang CY; Chang SH; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
    J Am Heart Assoc; 2018 Oct; 7(19):e008982. PubMed ID: 30371327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.
    Su TH; Chang SH; Chen PC; Chan YL
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28298371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
    Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
    PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
    Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
    BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
    Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
    Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study.
    Wu VC; Chen SW; Chou AH; Wu M; Ting PC; Chang SH; Wang CY; Lin MS; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
    Medicine (Baltimore); 2020 Mar; 99(12):e19575. PubMed ID: 32195968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    Puymirat E; Riant E; Aissaoui N; Soria A; Ducrocq G; Coste P; Cottin Y; Aupetit JF; Bonnefoy E; Blanchard D; Cattan S; Steg G; Schiele F; Ferrières J; Juillière Y; Simon T; Danchin N
    BMJ; 2016 Sep; 354():i4801. PubMed ID: 27650822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
    Wu VC; Chen SW; Chou AH; Ting PC; Chang CH; Wu M; Hsieh MJ; Wang CY; Chang SH; Lin MS; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
    PLoS One; 2019; 14(10):e0223380. PubMed ID: 31581275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of acute myocardial infarction in patients on treatment with beta-blockers or calcium antagonists. A study of 7,922 hospitalized first myocardial infarctions.
    Hansen O; Johansson BW; Gullberg B
    Cardiology; 1992; 80(5-6):382-91. PubMed ID: 1360331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
    LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
    JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.